NLRP3 inflammasome

Central innate immune sensor driving caspase-1 activation and IL-1β/IL-18 maturation

Expression
Overexpressed and hyperactivated
Evidence level
established

Role in pathogenesis

The NLRP3 inflammasome is excessively activated in AOSD patients. Upon stimulation by DAMPs and PAMPs through TLRs, NLRP3 recruits ASC adaptor proteins and activates caspase-1, which cleaves pro-IL-1β and pro-IL-18 into bioactive forms. NLRP3, caspase-1, and IL-1β expression are all significantly elevated in PBMCs from AOSD patients. NLRP3 inhibition reduces IL-1β and IL-18 protein expression in AOSD PBMCs.

Sources (3)

DetailsFeist E et al. (2018) Mechanisms, biomarkers and targets for adult-onset Still's disease · Nat Rev RheumatolPubMed
DetailsChen DY et al. (2017) Elevated expression of the NLRP3 inflammasome and its correlation with disease activity in adult-onset Still disease · J RheumatolPubMed
DetailsFautrel B et al. (2020) Adult-onset Still's disease · Presse MedPubMed